OncOS Early Access Program
Everything a clinician needs for precision oncology, in one interface.
High accuracy variant calling with detailed reporting on mutations found in each sample.
Clinical Trial matching
Patients are matched with trials that are seeking specific molecular profiles.
Reporting on Micro-satellite instability (MSI) and tumor mutational burden (TMB).
Chosen from a range of molecularly targeted FDA-approved, off label, or experimental therapies.
Register for beta test
AI-powered genomic insights
High accuracy variant calling
Desktop app for bulk uploading
Tumor Mutational Burden status
Quick data to insight turnaround
Compatibility with all NGS assays
Genomically matched therapies
For Research Use Only. Not for diagnostics procedures. OncOS results should not be used to inform clinical care without verification using an independent assay performed in an accredited laboratory.